Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

Clinical trial NCT01248884 · COMPLETED

Trial details

NCT number: NCT01248884
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Tetanus Poliomyelitis Hepatitis B Haemophilus Influenzae Type b Acellular Pertussis Diphtheria

Start date: 2010-12-09
Primary completion: 2012-01-05
Enrollment: 721

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.